CYP1B1

Cytochrome P450 Family 1 Subfamily B Member 1

Gene Information Card

Symbol CYP1B1
Full Name Cytochrome P450 Family 1 Subfamily B Member 1
Gene Type Protein coding
Chromosomal Location 2p22.2
NCBI Gene ID 1545 ncbi.nlm.nih.gov/gene/1545
Ensembl ID ENSG00000138061
UniProt ID Q16678
OMIM ID 601771
HGNC ID 2597
Aliases CP1B, GLC3A, P4501B1

Description

CYP1B1 encodes a member of the cytochrome P450 superfamily of enzymes. The protein localizes to the endoplasmic reticulum and metabolizes various xenobiotics, including polycyclic aromatic hydrocarbons, as well as endogenous substrates such as estradiol and arachidonic acid. CYP1B1 is expressed in multiple tissues, including the eye, and plays a critical role in ocular development. Mutations in CYP1B1 are a major cause of primary congenital glaucoma (PCG) and are also associated with other forms of glaucoma and certain cancers.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Primary Congenital Glaucoma (PCG) Loss-of-function mutations impair enzyme activity, leading to abnormal trabecular meshwork development and increased intraocular pressure. ClinVar, OMIM
Juvenile Open-Angle Glaucoma Heterozygous or compound heterozygous mutations reduce enzyme function, contributing to early-onset glaucoma. ClinVar, OMIM
Anterior Segment Dysgenesis Disrupted CYP1B1 activity alters retinoic acid signaling and ocular morphogenesis. OMIM, PubMed
Breast Cancer Polymorphisms (e.g., rs1056836) may alter estrogen metabolism, influencing cancer risk. COSMIC, NCBI

Expression Profile

Tissue Expression
Tissue nTPM level
Liver 0.4 Not detected
Kidney 0.6 Not detected
Eye (ciliary body) 12.3 Medium
Eye (retina) 8.5 Medium
Adrenal gland 5.2 Low
Prostate 3.1 Low
Breast 1.8 Low
Cell Line Expression
Cell Line nTPM Notes
HepG2 0.2 Not detected
MCF7 4.5 Low
ARPE-19 9.8 Medium
Primary trabecular meshwork cells 15.6 Medium
SK-OV-3 2.3 Low
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1169G>A (p.Arg390His) Missense Common in PCG (up to 30% in some populations) Loss of heme binding, reduced catalytic activity
c.182G>A (p.Gly61Glu) Missense Found in PCG families Disrupts protein folding, loss of function
c.355G>T (p.Glu119*) Nonsense Rare Premature truncation, complete loss of function
c.142C>T (p.Arg48Trp) Missense Observed in PCG Reduced enzyme activity
Mutation functional classification

Loss of Function (LOF)

Most CYP1B1 mutations in primary congenital glaucoma are loss-of-function, leading to reduced or absent enzyme activity.

Gain of Function (GOF)

No well-established gain-of-function mutations reported.

Dominant Negative (DN)

Some missense mutations may exert dominant-negative effects by interfering with wild-type enzyme dimerization, but evidence is limited.

Pathways

Metabolism of xenobiotics by cytochrome P450 (Reactome: R-HSA-211945)
Estrogen metabolism (Reactome: R-HSA-2142753)
Arachidonic acid metabolism (Reactome: R-HSA-2142750)
Retinoic acid metabolism (Reactome: R-HSA-5365859)

Protein Summary

CYP1B1 is a 543-amino acid microsomal cytochrome P450 enzyme with a molecular weight of approximately 60.8 kDa. It contains a conserved heme-binding domain and a P450 signature motif. The protein is anchored to the endoplasmic reticulum membrane via an N-terminal transmembrane domain. CYP1B1 catalyzes the hydroxylation of estradiol (primarily at the 4-position) and the oxidation of polycyclic aromatic hydrocarbons. Its expression is induced by aryl hydrocarbon receptor (AhR) ligands. In the eye, CYP1B1 is essential for normal trabecular meshwork development and aqueous humor outflow regulation.

Related Products

Product name Cat.No. Species Gene ID
CYP1B1 Knockout HEK293 Cell Line EDJ-KQ2285 Human 1545 Details Get a Quote
CYP1B1 Knockout A-549 Cell Line EDJ-KQ22636 Human 1545 Details Get a Quote
CYP1B1 Knockout HCT 116 Cell Line EDJ-KQ22637 Human 1545 Details Get a Quote
CYP1B1 Knockout HeLa Cell Line EDJ-KQ22638 Human 1545 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: